Objective To evaluate the efficacy and safety of different doses of intravenous immunoglobulin (IVIG) in the treatment of relapsing-remitting multiple sclerosis (RRMS).

• 目的 评价不同剂量免疫球蛋白治疗复发- 缓解型多发性硬化（RRMS）的疗效与安全性。